Literature DB >> 645885

Gonadal hormones and pathogenesis of occlusive arterial thrombosis.

A D Uzunova, E R Ramey, P W Ramwell.   

Abstract

Arterial thrombus formation was induced in male and female Wistar rats (3 mo) by inserting a loop-shaped polyethylene cannula into the abdominal aorta. Thrombogenesis was also induced in mature male and female New Zealand rabbits by constriction of the femoral artery and injection of ellagic acid. The criteria for thrombus development in the cannulated rats were: incidence of thrombosis (IT), obstruction time (OT), and thrombus weight (TW). We observed a significant sex difference in all these criteria of thrombogenesis in both rats and rabbits. Pretreatment of either sex with Depo-testosterone shortened OT, increased TW about fivefold in males and threefold in females, and increased mortality rate (MR) more than fourfold in both sexes. Prolonged pretreatment with Depo-testosterone increased in all aspects of thrombogenesis. Depo-estradiol had marginal ameliorating effects in male rats only. Both the antiandrogen Flutamide, and aspirin, significantly decreased the thrombogenic effects of testosterone. Thus, testosterone may be a significant risk factor in experimentally induced thrombogenesis in rats and rabbits.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 645885     DOI: 10.1152/ajpheart.1978.234.4.H454

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Cortical venous thrombosis following exogenous androgen use for bodybuilding.

Authors:  Olafur Sveinsson; Lars Herrman
Journal:  BMJ Case Rep       Date:  2013-02-05

2.  The Gordon Wilson Lecture. Regulation of thromboxane A2 receptors by testosterone: implications for steroid abuse and cardiovascular disease.

Authors:  P V Halushka; A Masuda; K Matsuda
Journal:  Trans Am Clin Climatol Assoc       Date:  1994

3.  Recurrent carotid artery stenosis following endarterectomy.

Authors:  M Thomas; S M Otis; M Rush; J Zyroff; R B Dilley; E F Bernstein
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.